Because the CONCERTA tablet is nondeformable and does not appreciably change in condition in the GI tract, CONCERTA must not ordinarily be administered to patients with preexisting significant gastrointestinal narrowing (pathologic or iatrogenic, such as: esophageal motility Diseases, little bowel inflammatory ailment, "small gut" syndrome on accou